Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limited sampling models for topotecan pharmacokinetics

L J van Warmerdam1, J Verweij, H Rosing

  • 1Dept of Clinical Pharmacy, Slotervaart Hospital, Amsterdam, The Netherlands.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An ultra-sensitive liquid chromatography tandem mass spectrometry method for the simultaneous quantification of <sup>2</sup>H<sub>6</sub>-alectinib and alectinib in human plasma to support a microtracer food-effect trial.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

Die Pharmazie·2023
Same author

Exposure-response analyses of BRAF- and MEK-inhibitors dabrafenib plus trametinib in melanoma patients.

Cancer chemotherapy and pharmacology·2023
Same author

Therapeutic drug monitoring-based precision dosing of oral targeted therapies in oncology: a prospective multicenter study.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-O-deacetylvinorelbine in human plasma using LC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2022
Same author

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.

Drug metabolism and disposition: the biological fate of chemicals·2022

New limited sampling models accurately estimate topotecan

Area of Science:

  • Pharmacokinetics
  • Drug metabolism
  • Population studies

Background:

  • Limited sampling models are needed for topotecan pharmacokinetic studies.
  • Estimating Area Under the Curve (AUC) and its metabolite AUC (AUC Tm) is crucial.

Purpose of the Study:

  • To develop and validate limited sampling models for topotecan pharmacokinetics.
  • To enable accurate estimation of topotecan AUC and AUC Tm from sparse data.

Main Methods:

  • Models developed and validated using 34 pharmacokinetic curves from 19 patients.
  • Utilized plasma concentrations at 2 hours post-infusion for estimation.

Main Results:

  • A single-point model was optimal for predicting topotecan AUC and AUC Tm.

Related Experiment Videos

  • Models demonstrated unbiased and precise predictions within a dosage range of 0.5-1.5 mg/m2/day.
  • Reliable prediction of clearance and total AUC was achieved; half-life prediction was imprecise.
  • Conclusions:

    • The developed limited sampling models are suitable for large-scale population pharmacokinetic studies.
    • These models can facilitate future research on topotecan's pharmacokinetic/pharmacodynamic relationships.